Systemic inflammation as a predictor of clinical outcomes after lower extremity angioplasty/stenting  Kenneth DeSart, MD, Kerri O'Malley, PhD, Bradley.

Slides:



Advertisements
Similar presentations
Regulation of human cytokines by Cordyceps militaris
Advertisements

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients.
Thomas L. Lynch, Mohamed Ameen Ismahil, Anil G. Jegga, Michael J
Volume 144, Issue 3, Pages e1 (March 2013)
Inelastic bandages maintain their hemodynamic effectiveness over time despite significant pressure loss  Giovanni Mosti, MD, Hugo Partsch, MD, PhD  Journal.
Jeffrey F. Scott, Lopa M. Das, Sayeeda Ahsanuddin, Yuqi Qiu, Amy M
Kenneth M. DeSart, MD, Khayree Butler, MD, Kerri A
Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue  Jolien Suurmond, MSc, Kim L.L. Habets,
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage- Mediated T Cell Suppression  Lysanne A. Lievense, MD, Robin Cornelissen, MD,
Volume 16, Issue 1, Pages (July 2014)
John D. Widdrington, PhD, MRCP, Aurora Gomez-Duran, PhD, Jannetta S
Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients  Stephany P. Monsanto, M.Sc.,
The role of viruses in acute exacerbations of asthma
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E
Katherine J. Baines, PhD, BBiomedSci (Hons), Jodie L
The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study  Rachel K. Middleton, BSc,
A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to.
Aromatase is required for female abdominal aortic aneurysm protection
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response  Suzanne Tintle, BS, Avner Shemer, MD, Mayte Suárez-Fariñas,
Craig H Selzman, MD, Stephanie A Miller, MD, Alden H Harken, MD 
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance.
Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy  Stephanie K. Beidler, MD, Christelle D.
The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients.
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with.
Young and Aged Blunt Trauma Patients Display Major Differences in Circulating Inflammatory Mediator Profiles after Severe Injury  Ashley J. Lamparello,
Proinflammatory role of stem cells in abdominal aortic aneurysms
Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,
Murine abdominal aortic aneurysm model by orthotopic allograft transplantation of elastase-treated abdominal aorta  Zhenjie Liu, MD, PhD, Qiwei Wang,
Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway in bronchial smooth muscle.
Volume 23, Issue 4, Pages (April 2018)
Volume 25, Issue 6, Pages e4 (November 2018)
Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes  Asifa S. Haider, Irma R. Cardinale,
Antimicrobial peptides and the skin immune defense system
Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade  Keith.
Neutrophils in antiretroviral therapy–controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment  Laure Campillo-Gimenez,
BALB/c scid mice have higher levels of macrophage-stimulating cytokines in circulation compared with BALB/c control mice. BALB/c scid mice have higher.
Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful  Salvatore Scali, MD, Virendra Patel,
Genomic and proteomic determinants of lower extremity revascularization failure: Rationale and study design  Peter R. Nelson, MD, Kerri A. O’Malley, PhD,
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications  Judie A. Howrylak, MD, Anne L.
Y. -P. Ding, M. -F. Liang, J. -b. Ye, Q. -h. Liu, C. -h. Xiong, B
Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2–high atopic dermatitis disease endotype  Nathan Dyjack,
Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery  Sara Arab, PhD, Igor E. Konstantinov, MD, PhD,
Volume 85, Issue 2, Pages (January 2014)
Macrophage polarization: Reaching across the aisle?
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes  Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.
Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease  Aurélie.
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Romain Gallet et al. BTS 2016;1:14-28
Volume 118, Issue 2, Pages (July 2004)
Subclavian revascularization in the age of thoracic endovascular aortic repair and comparison of outcomes in patients with occlusive disease  Salvatore.
Diastolic function predicts survival after renal revascularization
Abdominal aortic aneurysm anatomic severity grading score predicts implant-related complications, systemic complications, and mortality  W. Burke Best,
Lec.9 Cytokines.
Angiogenesis and arteriogenesis in limb ischemia
Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K
Local injury of the endometrium induces an inflammatory response that promotes successful implantation  Yulia Gnainsky, Ph.D., Irit Granot, Ph.D., Paulomi.
Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial  Scott A. Berceli, MD,
Grethe Bergseth, BS, John D
Innate immune activation occurs in acute food protein–induced enterocolitis syndrome reactions  Sam Mehr, MBBS, BMedSci, FRACP, FRCPA, Eric Lee, MBBS,
Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass  Chung-Hsi Hsing, MD, Mei-Yi Hsieh, MS, Wei-Yu Chen,
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes  Matthew A. Tyler, MD, Chris B.
The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α,
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling  Christine R. Mauro, MD, Kui Ding, MD, PhD, Hui Xue, MD, MMSc,
Presentation transcript:

Systemic inflammation as a predictor of clinical outcomes after lower extremity angioplasty/stenting  Kenneth DeSart, MD, Kerri O'Malley, PhD, Bradley Schmit, MD, Maria-Cecilia Lopez, PhD, Lyle Moldawer, PhD, Henry Baker, PhD, Scott Berceli, MD, PhD, Peter Nelson, MD, MS  Journal of Vascular Surgery  Volume 64, Issue 3, Pages 766-778.e5 (September 2016) DOI: 10.1016/j.jvs.2015.04.399 Copyright © 2016 Terms and Conditions

Fig 1 Supervised hierarchal clustering analysis of plasma inflammatory protein concentrations. Each patient sample at each time point is displayed across the x-axis, with each patient represented by the letters A through L. Each patient appears to have a unique inflammatory protein profile that remains relatively constant after endovascular intervention. Red represents upregulation, and blue represents downregulation. GMCSF, Granulocyte-macrophage colony-stimulating factor; IFN-γ, interferon-γ; IL, interleukin; IP-10, interferon γ-inducible protein 10; MCP-1, monocyte chemoattractant protein-1; MIP-1a, macrophage inflammatory protein 1 α; sCD40L, soluble CD40 ligand; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 2 Circulating monocyte phenotypes after lower extremity endovascular revascularization. A, Classic monocytes, identified by expression of cluster of differentiation (CD)14 only (CD14+/CD16−), remained stable over time. Proinflammatory monocytes, identified by coexpression of CD14 and CD16, also remained stable over time, although the presence of this subtype appeared to demonstrate a downward trend after revascularization. B and C, Integrin surface expression (CD18, CD11a, and CD11b) was similar between the two monocyte phenotypes. CD14+/CD16– cells demonstrated a greater percentage of human leukocyte antigen-DR1 (HLA-DR)+ cells across all time points compared with CD14+/CD16+ cells (P = .021). Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 3 Canonical pathways representing the 31 genes demonstrating a significant change in the initial 1 month after the intervention. Multiple-testing corrected P values were used to control the rate of false discoveries. The first three pathways are considered significantly enriched for this gene set (calculated using the Benjamini-Hochberg [B-H] method, false discovery rate [FDR]-corrected P < .05). The black boxes represent the fraction of the predictive genes in each pathway. FAK, Focal adhesion kinase; HER-2, human epidermal growth factor receptor 2. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 4 Supervised hierarchal clustering analysis of 31 genes demonstrating a significant change in expression after revascularization. Mean expression data at each time point are presented across the x-axis. The vertical dendrogram reveals two distinct gene clusters with differential expression. Cluster A consists of nine genes that exhibit early upregulation (preoperatively, 0.08 days, and 1 day), and cluster B consists of 22 genes that exhibit late upregulation (7 days and 28 days). Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 5 Ingenuity Pathway Analysis of 31 genes demonstrates a significant change in expression after revascularization. The network encompassing this gene set is presented at four time points after intervention. Red indicates upregulation and blue indicates downregulation (relative to preoperative expression levels). Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 6 Unsupervised hierarchal clustering analysis of mean plasma inflammatory protein concentrations at each time point for both outcome groups are displayed across the x-axis. The horizontal dendrogram reveals a tight clustering of the two outcome groups, demonstrating two divergent patterns of protein expression. Red represents upregulation and blue represents downregulation. GMCSF, Granulocyte-macrophage colony-stimulating factor; IFN-γ, interferon-γ; IL, interleukin; IP-10, interferon γ-inducible protein 10; MCP-1, monocyte chemoattractant protein-1; MIP-1a, macrophage inflammatory protein 1 α; sCD40L, soluble CD40 ligand; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 7 Clustering analysis of plasma inflammatory protein concentrations. A, Mean plasma protein concentrations at each time point for both outcome groups are displayed across the x-axis. The heat map reveals two divergent patterns of protein expression across all time points between the two outcome groups. B-D, A dynamic clustering algorithm identified three distinct patterns of protein expression. The mean fold-change from baseline (preoperative) concentrations of all proteins within each cluster for each outcome group is displayed. All three clusters demonstrated highly significant outcome-dependent differences (analysis of variance). GMCSF, Granulocyte-macrophage colony-stimulating factor; IFN-γ, interferon-γ; IL, interleukin; IP-10, interferon γ-inducible protein 10; MCP-1, monocyte chemoattractant protein-1; MIP-1a, macrophage inflammatory protein 1 α; sCD40L, soluble CD40 ligand; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 8 Canonical pathways associated with the subset of day 1 genes that differentiate long-term success or failure of the intervention. The 10 most significant canonical pathways representing these 39 genes are presented. Multiple-testing corrected P values were used to control the rate of false discoveries. The black boxes represent the fraction of predictive genes in each pathway. B-H, Benjamini-Hochberg; ERKs, extracellular-signal-regulated kinases; NRF-2, nuclear factor erythroid 2-related factor 2. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 9 Unsupervised hierarchal clustering analysis of the subset of 39 day 1 genes that differentiate long-term success or failure. Mean expression data for both outcome groups at each time point is presented across the x-axis. Although this gene subset was selected for its ability to predict outcome at 1 day after revascularization, the primary node of clustering separates the outcome groups across all time points. Red represents upregulation and blue represents downregulation. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Fig 10 Ingenuity Pathway Analysis of the subset of day 1 genes that differentiate long-term success or failure, divided into two groups (F and G) after an unsupervised cluster analysis. The network pathway on the left contains 11 of the 25 cluster F genes and is primarily involved in cell death and survival. The pathway on the right contains 10 of the 12 cluster G genes and is primarily associated with cell-cycle regulation. Class prediction genes are represented in gray. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Supplementary Fig 1 (online only) Kaplan-Meier estimations of primary and secondary patency. Cumulative 1-year and 2-year primary patency was 79% and 66%, and 1-year and 2-year secondary patency was 83% and 76%. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Supplementary Fig 2 (online only) Plasma inflammatory protein levels after endovascular revascularization. By 24 hours after the intervention, the increase in the interleukin-6 (IL-6) concentration (16.0 ± 5.0 ng/mL) reached the Bonferroni-adjusted significance level compared with the preoperative levels (7.0 ± 4.7 ng/mL; P = .001). The plasma concentrations of IL-8, monocyte chemoattractant protein-1 (MCP-1), and soluble CD40 ligand (sCD40L) also demonstrated alterations after the intervention; however, these changes did not reach significance. The horizontal line in the middle of each box indicates the median; the top and bottom borders of the box mark the 75th and 25th percentiles, respectively, the whiskers mark the 90th and 10th percentiles, and the black circles indicate outliers. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions

Supplementary Fig 3 (online only) Unsupervised hierarchal clustering analysis of plasma inflammatory protein concentrations. Each patient sample at each time point is displayed across the x-axis, with each patient represented by the letters A through L. The horizontal dendrogram identifies the individual patient's plasma protein signature as the dominant clustering effect. Each patient appears to have a unique inflammatory protein profile that remains relatively constant after endovascular intervention. Red represents upregulation and blue represents downregulation. GMCSF, Granulocyte-macrophage colony-stimulating factor; IFN-γ, interferon-γ; IL, interleukin; IP-10, interferon γ-inducible protein 10; MCP-1, monocyte chemoattractant protein-1; MIP-1a, macrophage inflammatory protein 1 α; sCD40L, soluble CD40 ligand; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor. Journal of Vascular Surgery 2016 64, 766-778.e5DOI: (10.1016/j.jvs.2015.04.399) Copyright © 2016 Terms and Conditions